Gateway Investment Advisers LLC raised its holdings in Baxter International Inc (NYSE:BAX) by 5.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 429,311 shares of the medical instruments supplier’s stock after acquiring an additional 20,467 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Baxter International were worth $27,751,000 as of its most recent filing with the SEC.
Other institutional investors have also added to or reduced their stakes in the company. Family Capital Trust Co purchased a new position in shares of Baxter International in the fourth quarter valued at $103,000. Grove Bank & Trust increased its position in shares of Baxter International by 526.0% in the third quarter. Grove Bank & Trust now owns 2,285 shares of the medical instruments supplier’s stock valued at $143,000 after buying an additional 1,920 shares in the last quarter. Steward Partners Investment Advisory LLC purchased a new position in shares of Baxter International in the third quarter valued at $175,000. Hutner Capital Management Inc. purchased a new position in shares of Baxter International in the third quarter valued at $203,000. Finally, Stonebridge Capital Advisors LLC purchased a new position in shares of Baxter International in the third quarter valued at $204,000. 83.82% of the stock is owned by institutional investors.
Shares of Baxter International Inc (NYSE:BAX) opened at $68.20 on Thursday. The company has a market capitalization of $36,868.77, a PE ratio of 36.67, a P/E/G ratio of 2.03 and a beta of 0.69. Baxter International Inc has a 52-week low of $45.47 and a 52-week high of $69.65. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.22 and a current ratio of 2.80.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, January 2nd. Investors of record on Friday, December 1st were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date was Thursday, November 30th. Baxter International’s dividend payout ratio is presently 34.41%.
A number of research analysts have recently weighed in on the company. Zacks Investment Research upgraded Baxter International from a “sell” rating to a “hold” rating in a research report on Thursday, January 4th. Royal Bank of Canada restated a “hold” rating and issued a $60.00 price target on shares of Baxter International in a research report on Tuesday, October 3rd. Cowen set a $68.00 price target on Baxter International and gave the company a “hold” rating in a research report on Sunday, October 15th. Bank of America upgraded Baxter International from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 2nd. Finally, Evercore ISI assumed coverage on Baxter International in a research report on Wednesday, January 3rd. They issued an “outperform” rating and a $71.00 price target for the company. Seven analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. Baxter International has a consensus rating of “Buy” and a consensus target price of $68.64.
In other Baxter International news, SVP Giuseppe Accogli sold 28,641 shares of Baxter International stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $67.00, for a total value of $1,918,947.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Third Point Llc sold 5,000,000 shares of Baxter International stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $64.23, for a total value of $321,150,000.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,061,991 shares of company stock valued at $325,245,035. 0.05% of the stock is currently owned by company insiders.
WARNING: This report was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.com-unik.info/2018/01/18/baxter-international-inc-bax-holdings-raised-by-gateway-investment-advisers-llc.html.
Baxter International Profile
Baxter International Inc, through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products.
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.